EAN 2026 | The development of a deep learning tool to detect drug-resistant epilepsy with EEG

Manuel Toledo, MD, PhD, VHIR Vall d’Hebron Institut de Recerca, Barcelona, Spain, shares insights into the development of a deep learning tool to detect drug-resistant epilepsy with EEG. Dr Toledo explains how this approach has the potential to accelerate diagnosis, improve the identification of drug resistance, and support more informed treatment decisions. This interview took place at the 12th Congress of the European Academy of Neurology (EAN) in Geneva, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.